Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock

American Heart Journal
R C Becker


Although thrombolytic therapy has been shown to limit infarct size, preserve left ventricular function, and improve survival in most subgroups of patients with acute MI, a benefit has not been demonstrated in patients with clinical left ventricular dysfunction or overt cardiogenic shock before treatment is initiated. The reason(s) for the lack of benefit derived from thrombolytic therapy in these settings is unclear. Left ventricular dysfunction and overt cardiogenic shock are the result of extensive myocardial necrosis, typically in excess of 30% of the left ventricle, which progresses over time. The available data suggest that thrombolytic efficacy is decreased because of either hemodynamic, mechanical, or metabolic factors. As a result coronary patency is rarely achieved in a timely fashion, and if patency is achieved it typically is not maintained. The ability of mechanical revascularization by means of balloon angioplasty to reduce mortality suggests that reperfusion is a key determinant of outcome even among patients with large infarctions and early signs of left ventricular dysfunction. Thrombolytic therapy, which is widely available and extensively tested, represents the standard of care for patients with acute MI. Its ...Continue Reading


Aug 16, 1978·Molecular and Cellular Biochemistry·K C Robbins
Mar 1, 1978·The American Journal of Cardiology·A L GutovitzR S Roberts
Jan 1, 1976·Journal of Biomechanics·B D Seeley, D F Young
Jul 1, 1975·IEEE Transactions on Bio-medical Engineering·S E Logan
Mar 11, 1992·Journal of the American College of Cardiology·M D HibbardB J Gersh
Apr 1, 1992·Journal of the American College of Cardiology·A R MoosviS Goldstein
Nov 11, 1991·Journal of the American College of Cardiology·W P SantamoreJ D Ogilby
Mar 1, 1991·Journal of the American College of Cardiology·L LeeW W O'Neill
Feb 1, 1989·Journal of the American College of Cardiology·M CohenR Gorlin
Apr 1, 1986·Journal of the American College of Cardiology·M L SimoonsA van der Laarse
Aug 1, 1988·The American Journal of Cardiology·J E DalenG Knatterud
Apr 1, 1988·Journal of the American College of Cardiology·J L RitchieJ W Kennedy
Feb 1, 1988·American Journal of Hematology·G Marx
Oct 1, 1988·Journal of the American College of Cardiology·P B KurnikP A Ludbrook
May 1, 1987·Journal of the American College of Cardiology·R W JeremyP J Harris
Feb 1, 1986·The Annals of Thoracic Surgery·S J PhillipsC Kongtahworn
Jun 1, 1985·International Journal of Cardiology·D HigginsP Nemir
Dec 7, 1974·Lancet·M G MillerM Alexander
Sep 1, 1973·Annals of Surgery·E D MundthW G Austen
Jul 15, 1971·The New England Journal of Medicine·D L PageC A Sanders
Apr 1, 1967·Circulation·M D KleinR Gorlin
Oct 1, 1967·The American Journal of Cardiology·T Killip, J T Kimball
Jan 1, 1982·Thrombosis Research·B Blombäck, M Okada
Feb 1, 1984·Nihon juigaku zasshi. The Japanese journal of veterinary science·K Sasaki
Oct 1, 1982·Circulation·B FreedmanD T Kelly
Jan 1, 1980·Circulation·J S SchwartzJ N Cohn
Apr 1, 1955·The American Journal of Medicine·M J BINDERC M AGRESS


Mar 10, 1998·Clinical Cardiology·W L Barry, I J Sarembock
Jan 1, 1995·Journal of Thrombosis and Thrombolysis·G N Levine, J S Hochman
Jul 29, 2008·Emergency Medicine Clinics of North America·Robin M NaplesChris A Ghaemmaghami
Oct 30, 2007·Critical Care Clinics·Hitinder S Gurm, Eric R Bates
Mar 29, 2005·Angiology·Konstantina P BoukiEvaggelos Papasteriadis
Aug 3, 2005·Journal of Intensive Care Medicine·Claire S Duvernoy, Eric R Bates
Aug 13, 2003·Circulation·Edmond W ChenInvestigators in the National Registry of Myocardial Infarction 2
Dec 9, 1995·Journal of Intensive Care Medicine·T M ChouC L Wolfe
May 18, 2010·Hospital Practice·Nitasha Sarswat, Steven M Hollenberg

Related Concepts

Myocardial Infarction
Shock, Cardiogenic
Thrombolytic Therapy
Left Ventricular Function
Hospital Mortality

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.